A multicentre, prospective registry of patients with systemic sclerosis in Japan: baseline patient characteristics

Keyphrases

• Japan 100%
• Patient Characteristics 100%
• Systemic Sclerosis 100%
• Prospective Registry 100%
• Gastrointestinal Involvement 50%
• Topos 50%
• Interstitial Lung Disease 25%
• Clinical Outcomes 25%
• Patient-reported Outcomes 25%
• Autoantibodies 25%
• Baseline Characteristics 25%
• Pulmonary Hypertension 25%
• Patient Global Assessment 25%
• Upper Gastrointestinal Tract 25%
• Contemporary Practice 25%
• Baseline Data 25%
• Autoantibody Profile 25%
• Organ Involvement 25%
• Heart Involvement 25%
• Physician Global Assessment 25%
• Medical Center 25%
• Diffuse Cutaneous Systemic Sclerosis 25%
• Valuable Resources 25%
• Clinical Spectrum 25%
• Anticentromere 25%
• Anti-topoisomerase I Antibodies 25%
• Electronic Data Capture System 25%
• Anti-RNA Polymerase III Antibodies 25%
• World Data 25%
• U1 snRNP 25%
• Scleroderma Renal Crisis 25%
• Modern Treatment 25%
• Lower Gastrointestinal 25%
• Organ Manifestations 25%

Medicine and Dentistry

• Patient Characteristics 100%
• Systemic Scleroderma 100%
• Autoantibodies 40%
• Interstitial Lung Disease 20%
• Pulmonary Hypertension 20%
• Scleroderma 20%
• Topoisomerase 20%
• Ribonucleoprotein 20%
• DNA Directed RNA Polymerase III 20%
• Patient-Reported Outcome 20%
• Real-World Data 20%

Immunology and Microbiology

• Systemic Scleroderma 100%
• Autoantibodies 40%
• RNA Polymerase 20%
• Scleroderma 20%
• Lung 20%